The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases
Abstract
Previous studies in our laboratory have shown that in NIH3T3-5HT2A cells, 5-HT-induced AA release is PLA2-coupled and independent of 5-HT2A receptor-mediated PLC activation. Although 5-HT2A receptor-mediated PLC activation is known to be Galphaq-coupled, much less is understood about 5-HT2A receptor-mediated PLA2 activation. Therefore, the studies presented here were aimed at elucidating the signal transduction pathway linking stimulation of the 5-HT2A receptor to PLA2 activation. By employing various selective inhibitors, toxins, and antagonistic peptide constructs, we propose that the 5-HT2A receptor can couple to PLA2 activation through two parallel signaling cascades. Initial experiments were designed to examine the role of pertussis toxin-sensitive G proteins, namely Galphai/o, as well as pertussis toxin-insensitive G proteins, namely Galpha12/13, in 5-HT-induced AA release. Furthermore, inactivation of both Gbetagamma heterodimers and Rho proteins resulted in decreased agonist-induced AA release, without having any effect on PLC-IP accumulation. We also demonstrated 5-HT2A receptor-mediated phosphorylation of ERK1,2 and p38. Moreover, pretreatment with selective ERK1,2 and p38 inhibitors resulted in decreased 5-HT-induced AA release. Taken together, these results suggest that the 5-HT2A receptor expressed in NIH3T3 cells can couple to PLA2 activation though a complex signaling mechanism involving both Galphai/o-associated Gbetagamma-mediated ERK1,2 activation and Galpha12/13-coupled, Rho-mediated p38 activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Via activation of 5-HT2AR, psychedelics activate intracellular signaling pathways such as PLC, PLA, and Src (88–90).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [88]
Citations
Cites
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
Berridge, M. J., Dawson, R. M. C., Downes, C. P., Heslop, J. P., & Irvine, R. F. (1983) · Biochemical Journal · doi:10.1042/bj2120473 · Cited by 1,954
cPLA2 is phosphorylated and activated by MAP kinase
Lin, L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A., & Davis, R. J. (1993) · Cell · doi:10.1016/0092-8674(93)90666-e · Cited by 1,851
Clark, J. D., Lin, L.-L., Kriz, R. W., Ramesha, C. S., Sultzman, L. A., Lin, A. Y., Milona, N., & Knopf, J. L. (1991) · Cell · doi:10.1016/0092-8674(91)90556-e · Cited by 1,688
Katada, T., & Ui, M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3129 · Cited by 811
Direct Stimulation of the Guanine Nucleotide Exchange Activity of p115 RhoGEF by Gα 13
Hart, M. J., Jiang, X., Kozasa, T., Roscoe, W., Singer, W. D., Gilman, A. G., Sternweis, P. C., & Bollag, G. E. (1998) · Science · doi:10.1126/science.280.5372.2112 · Cited by 780
Regulatory Functions of Phospholipase A2
Murakami, M., Nakatani, Y., Atsumi, G., Inoue, K., & Kudo, I. (1997) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v17.i3-4.10 · Cited by 542
Sekine, A., Fujiwara, M., & Narumiya, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81834-8 · Cited by 541
Nemenoff, R. A., Winitz, S., Qian, N. X., Putten, V. V., Johnson, G. L., & Heasley, L. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53948-x · Cited by 522
Clark, J., Schievella, A., Nalefski, E. A., & Lin, L. (1995) · Journal of Lipid Mediators and Cell Signalling · doi:10.1016/0929-7855(95)00012-f · Cited by 515
Cited by
Sorted by citations
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
“The PLA2 signaling pathway is more complex than the PI turnover cascade, apparently involving multiple G proteins and the extracellular signal-regulated kinase (ERK) 1/2 and p38 mitogenactivated protein kinases (MAPKs), at least in NIH3T3 cells (Kurrasch-Orbaugh et al., 2003a).”
BackgroundSelf-citationNichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Self-citationFunctional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B. K., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,119
“…it has been shown that AA signaling probably involves G i/o and G 12/13, as well as G , Rho, mitogen-activated protein kinase kinase 1/2, and p38 MAPK (Kurrasch-Orbaugh et al., 2003a), indicating that more than one signaling cascade is responsible for 5-HT2A receptor-mediated AA release.”
BackgroundInfluentialSelf-citationGonzález-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925
Phospholipase A2 in the central nervous system
Sun, G. Y., Xu, J., Jensen, M. D., & Simonyi, Á. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300016-jlr200 · Cited by 391
“PLA2 and AA release involved in both the Gi/o-associated G-mediated ERK1/2 and the G12/13-coupled, Rho-mediated p38 MAP kinase pathways (41, 42).”
BackgroundThe role of serotonin 5-HT2A receptors in memory and cognition
Zhang, G., & Stackman, R. W. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00225 · Cited by 398
“5-HT2AR activation also stimulates the Gα12/13-phospholipase A2 signal transduction pathway, which promotes arachidonic acid release (Kurrasch-Orbaugh et al., 2003a,b).”
BackgroundFarooqui, A. A., Ong, W., & Horrocks, L. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.7 · Cited by 378
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Halberstadt, A. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.016 · Cited by 312
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript and p38 MAP kinase), Akt, and phospholipase D (dependent on the small G protein ADPribosylation factor-1 (ARF1)) (Kurrasch-Orbaugh et al., 2003a; González-Maeso et al., 2007; Schmid and Bohn, 2010; Barclay et al., 2011).”
BackgroundInfluentialPlatelets and cancer: a casual or causal relationship: revisited
Menter, D. G., Tucker, S. C., Kopetz, S., Sood, A. K., Crissman, J. D., & Honn, K. V. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9498-0 · Cited by 324
The neural basis of psychedelic action
Kwan, A. C., Olson, D. E., Preller, K. H., & Roth, B. L. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01177-4 · Cited by 330
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
López‐Giménez, J. F., & González‐Maeso, J. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_478 · Cited by 325
“For example, relative to 5-HT, some agonists, such as 3-trifluoromethylphenylpiperazine (TFMPP), preferentially activate the PLC-IP J.F. López-Giménez and J. González-Maeso pathway, whereas other agonists, such as LSD, showed a preference for the PLA2AA pathway.”
BackgroundInfluentialde Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724606 · Cited by 269
Barnes, N. M., Ahern, G. P., Bécamel, C., Bockaert, J., Camilleri, M., Chaumont‐Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C. F., Gershon, M. D., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 274
Moreno, J. L., Holloway, T. D., Albizu, L., Sealfon, S. C., & González‐Maeso, J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.046 · Cited by 235
“However, some reports have implicated pertussis toxin-sensitive Gi/o proteins in the cel1lular responses mediated by 5-HT2AR activation [22,30].”
BackgroundAgonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo
Schmid, C. L., Raehal, K. M., & Bohn, L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708862105 · Cited by 231
Functions of 5-HT2A receptor and its antagonists in the cardiovascular system
Nagatomo, T., Rashid, M., Muntasir, H. A., & Komiyama, T. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.005 · Cited by 186
Schmid, C. L., & Bohn, L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1665-10.2010 · Cited by 181
“Diverse ligands to the 5-HT2AR have been shown to differentially activate downstream signaling cascades both in vitro and in vivo (Berg et al., 1998; Kurrasch-Orbaugh et al., 2003; González-Maeso et al., 2007; Schmid et al., 2008).”
BackgroundSeyedabadi, M., Ghahremani, M. H., & Albert, P. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.006 · Cited by 156
Lipid agonism: The PIP2 paradigm of ligand-gated ion channels
Hansen, S. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.01.011 · Cited by 146
“A third important class of lipases phospholipase A2 (PLA2) also exhibits GPCR regulation [103].”
BackgroundKelly, P., Casey, P. J., & Meigs, T. E. (2007) · Biochemistry · doi:10.1021/bi700235f · Cited by 137
Serotonergic signaling: multiple effectors and pleiotropic effects
Masson, J., Emerit, M. B., Hamon, M., & Darmon, M. C. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.50 · Cited by 132
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
Olson, D. E. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00812 · Cited by 146
How serotonin receptors regulate morphogenic signalling in neurons
Wirth, A., Holst, K., & Ponimaskin, E. G. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.007 · Cited by 125
Knock, G. A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.029 · Cited by 110
Xia, Y., Fu, Z., Hu, J., Huang, C. Y., Paudel, O., Cai, S., Liedtke, W., & Sham, J. S. K. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00099.2013 · Cited by 108
On the analysis of ligand-directed signaling at G protein-coupled receptors
Ehlert, F. J. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0260-4 · Cited by 94
“It has also been shown that several signaling proteins including isoforms of adenylate cyclase (Kurrasch-Orbaugh et al. 2003) and regulators of G protein signaling proteins (Neubig 2002) as well as proteins that interact with GPCRs (Bockaert et al.”
BackgroundDuan, W., Cao, D., Wang, S., & Cheng, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00375 · Cited by 81
Garcia, E. E., Smith, R. L., & Sanders‐Bush, E. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.03.013 · Cited by 78
“, G13 activation of PLD (McGrew et al., 2002;Kurrasch-Orbaugh et al., 2003) or Gi/o activation of the erg signaling pathway (Gonzales Maeso et al.”
BackgroundThe role of phospholipases A2 in schizophrenia
Law, M. H., Cotton, R. G. H., & Berger, G. E. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001819 · Cited by 73
Parrish, J. C., & Nichols, D. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04173.x · Cited by 63
Self-citationNichols, C. D., & Sanders‐Bush, E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02515.x · Cited by 62
Regulation of Serotonin-Induced Trafficking and Migration of Eosinophils
Kang, B., Ha, S., Bahaie, N. S., Hosseinkhani, M., Ge, X.-N., Blumenthal, M., Rao, S. P., & Sriramarao, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054840 · Cited by 56
“Additionally, in NIH3T3 fibroblasts transformed to stably express 5-HT2A, stimulation of 5-HT2A receptors has been shown to activate the PLA2 signaling pathways via G12/13 coupling [60].”
BackgroundPUFA and their derivatives in neurotransmission and synapses: a new hallmark of synaptopathies
Miceli, M. D., Bosch‐Bouju, C., & Layé, S. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120000129 · Cited by 56
Holze, F., Singh, N., Liechti, M. E., & D’Souza, D. C. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.01.007 · Cited by 62
Daniele, S., Pozzo, E. D., Zappelli, E., & Martini, C. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.006 · Cited by 57
“Specifically, ERK1/2 activation and p38 pathway inhibition have been reported to involve agonistic effects at the 5HT 1A serotonin receptor [63,64], inhibition of the 5HT 2A serotonin receptor [63], and inhibition of SERT [65,66].”
BackgroundSerotonin 2A (5-HT2A) Receptor Function: Ligand-Dependent Mechanisms and Pathways
Chattopadhyay, A. (2007) · CRC Press eBooks · doi:10.1201/9781420005752-11 · Cited by 56
The Effects of Hallucinogens on Gene Expression
Martin, D. A., & Nichols, C. D. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_479 · Cited by 51
“In mice lacking the Gaq protein, c-Fos induction following DOI is abolished, and the head-twitch response is markedly reduced (Garcia et al. 2007).”
BackgroundResultInfluentialActivation, internalization, and recycling of the serotonin 2A receptor by dopamine
Bhattacharyya, S., Raote, I., Bhattacharya, A., Miledi, R., & Panicker, M. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606578103 · Cited by 51
Wolf, G., Singh, S., Blakolmer, K., Lerer, L. B., Lifschytz, T., Heresco‐Levy, U., Lotan, A., & Lerer, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01832-z · Cited by 50
“Through stimulation of the 5-HT2A receptor, psychedelics activate intracellular signaling pathways such as PLC, PLA, and Src [138, 139].”
BackgroundSerotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
Canal, C. E. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_107 · Cited by 49
“…arachidonic acid release (phospholipase A activation) do not reveal unique signaling properties of psychedelics, and like the phospholipase C-β-inositol phosphate pathway, many psychedelics are partial agonists relative to 5-HT (Kurrasch-Orbaugh et al. 2003a, b; Moya et al. 2007).”
BackgroundHow much do we know about the coupling of G-proteins to serotonin receptors?
Giulietti, M., Vivenzio, V., Piva, F., Principato, G., Bellantuono, C., & Nardi, B. (2014) · Molecular Brain · doi:10.1186/s13041-014-0049-y · Cited by 46
“Gαi/o-?-? In mouse NIH3T3 cells cPLA2 (not PLC, IP3) (Kurrasch-Orbaugh, 2003) [52] Gα12/13-?-?”
Settimo, L., & Taylor, D. M. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117742101 · Cited by 45
“…stress-related PERK/eIF2 α/ ATF4 pathway (Jiang et al., 2014) and also that 5-HT 2A agonism activates the mitogen-activated protein kinase p38 (Kurrasch-Orbaugh et al., 2003), it is evident that trazodone’s antagonist activity on the 5-HT 2A receptor is expected to decrease the activity of…”
Govindula, A., Ranadive, N., Nampoothiri, M., Rao, C. M., Arora, D. S., & Mudgal, J. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10064-z · Cited by 47
Structure–Activity Relationships of Phenylalkylamines as Agonist Ligands for 5‐HT2A Receptors
Blaazer, A. R., Smid, P., & Kruse, C. G. (2008) · ChemMedChem · doi:10.1002/cmdc.200800133 · Cited by 43
Boas, G. R. V., Lavorato, S. N., Paes, M. M., Galdino, P. M., Rescia, V. C., Cunha, M. S., de Magalhães-Filho, M. F., Ponsoni, L. F., de Carvalho, A. A. V., de Lacerda, R. B., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14020148 · Cited by 42
“The “atypical” coupling represented by the blue circle demonstrates the activation of phospholipase A2 (PLA2) mediated by the 5-HT2A receptor and the subsequent release of arachidonic acid, described as a result of Gα12/13coupled, Rho-mediated, p38 activation in NIH 3T3 cells [48].”
BackgroundPharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
Gaitonde, S. A., Avet, C., Revenga, M. D. L. F., Blondel-Tepaz, É., Shahraki, A., Pastor, A. M., Talagayev, V., Robledo, P., Kolb, P., Selent, J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02531-7 · Cited by 42
“Although earlier studies have implicated G α 12/ 13 in the activation of the phospholipase A 2 (PLA 2 ) pathway downstream of the 5-HT 2A R, other studies have also shown that there is no evidence for a direct coupling of these G proteins by the 5-HT 2A R [20, 43, 46].”
BackgroundPeddie, C. J., Davies, H. A., Colyer, F. M., Stewart, M. G., & Rodríguez, J. J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.003 · Cited by 39
“5-HT2ARs also couple to phospholipase A2, generating the second messenger arachidonic acid, and can activate the ERK and p38 signalling cascades (Kurrasch-Orbaugh et al., 2003a,b; Parrish and Nichols, 2006).”
Pottie, E., & Stove, C. P. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15570 · Cited by 37
“Overall, biased agonism exerted by (psychedelic) agonists at the 5- HT2AR, as determined by in vitro functional assays, has mostly been discussed by comparison of outcomes in IP accumulation and AA release assays (Berg et al., 1998; Kurrasch- Orbaugh, Watts, et al., 2003; Marti- Solano et al., 2015; McLean, Parrish, e…”
BackgroundInfluentialXiang, M., Jiang, Y., Hu, Z., Yang, Y., Du, X., Botchway, B. O. A., & Fang, M. (2019) · PubMed Central · Cited by 36
Oufkir, T., & Vaillancourt, C. (2011) · Placenta · doi:10.1016/j.placenta.2011.09.005 · Cited by 36
“One interesting pathway that we will explore in our follow-up study is that of phospholipase A2 (PLA2) which has been shown to be activated by the 5-HT2A-PKC-ERK1/2 axis [49,50].”
BackgroundSignificance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate
Jiménez, J. H., & Bouso, J. C. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221104054 · Cited by 39
“Furthermore, PLA2 engagement requires a smaller receptor occupancy: binding to an estimated 3% of the receptors elicits the maximum response (Emax) versus a 7% occupancy for PLC-coupled 5-HT2A (Kurrasch-Orbaugh et al., 2003b).”
BackgroundInfluentialWeinstein, H. (2005) · The AAPS Journal · doi:10.1208/aapsj070485 · Cited by 34
5-HT2A and mGlu2/3 receptor interactions
Wischhof, L., & Koch, M. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000183 · Cited by 33
“Moreover, the two signaling pathways appear to have different receptor reserves in that activation of a much smaller fraction of the 5-HT2A receptor is required for the stimulation of the PLA2-mediated cascade versus PLC activation (Kurrasch-Orbaugh et al., 2003a, 2003b).”
BackgroundSerum calcium‐independent phospholipase A2 activity in bipolar affective disorder
Ross, B. M., Hughes, B., Kish, S. J., & Warsh, J. J. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00299.x · Cited by 33
The renaissance in psychedelic research: What do preclinical models have to offer
Murnane, K. S. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.08.003 · Cited by 35
The crosstalk between 5-HT2AR and mGluR2 in schizophrenia
Saha, S., & González‐Maeso, J. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109489 · Cited by 30
Ősz, B.-E., Jîtcă, G., Sălcudean, A., Rusz, C.-M., & Vari, C.-E. (2023) · Pharmaceuticals · doi:10.3390/ph16040566 · Cited by 32
The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity
Gupta, S., Bhatnagar, R. K., Gupta, D., Maharaj Kumari, K., & Chopra, A. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06777-z · Cited by 32
Valentín-Berríos, S., González-Velázquez, W., Pérez-Sánchez, L., Gonzalez-Mendez, R. R., & Valle, N. R.-D. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-100 · Cited by 30
“In higher eukaryotes, members of the Gα class are known to regulate adenylate cyclase [20], cGMP phosphodiesterase [21], phosphoinositide-3-kinase [22], calcium and potassium channels [22-24], and the activity of phospholipases [9,25-28].”
Retamal, J. S., Grace, M. S., Dill, L. K., Ramírez-García, P. D., Peng, S., Gondin, A. B., Bennetts, F. M., Alvi, S., Rajasekhar, P., Almazi, J. G., et al. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00593-7 · Cited by 28
Song, J.-L., Zheng, S., He, R., Gui, L., Lin, M., & Sham, J. S. K. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106860 · Cited by 27
Giovanni, G. D., & Deurwaerdère, P. D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.004 · Cited by 25
“Nonetheless, this phenomenon would not account for their psychogenic effects; lisuride has a profile similar to DOB in this regard (Kurrasch-Orbaugh et al., 2003b).”
Bhattacharjee, A. K., Chang, L., White, L., Bazinet, R. P., & Rapoport, S. I. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600290 · Cited by 25
Role of a small G protein Ras in cellular immune response of the beet armyworm, Spodoptera exigua
Lee, S., Shrestha, S. S., Surakasi, V. P., & Kim, Y. (2010) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2010.12.003 · Cited by 25
Serotonergic Suppression of Mouse Prefrontal Circuits Implicated in Task Attention
Tian, M. K., Schmidt, E. F., & Lambe, E. K. (2016) · eNeuro · doi:10.1523/eneuro.0269-16.2016 · Cited by 26
“, 2010; Weber and Andrade, 2010; Avesar and Gulledge, 2012), although previous work has demonstrated the capacity of serotonin and 5-HT2A agonists to exert direct inhibitory effects through 5-HT2A receptors or heteromers (Carr et al., 2002; Kurrasch-Orbaugh et al., 2003; GonzálezMaeso et al., 2007; Moreno et al., 2011…”
BackgroundChronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized rats
Qu, Y., Chang, L., Klaff, J., Seemann, R., GREENSTEIN, D. K., & Rapoport, S. I. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.01.008 · Cited by 23
Cloëz-Tayarani, I., Kayyali, U. S., Fanburg, B. L., & Cavaillon, J. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.09.006 · Cited by 21
The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies
Low, Z. X. B., Ng, W. S., Lim, E. S. Y., Goh, B. H., & Kumari, Y. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111139 · Cited by 22
Psychedelics action and schizophrenia
Maćkowiak, M. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00546-5 · Cited by 22
“Activation of the 5-HT 2A receptor also induces G i/o -dependent Gβγ -associates stimulation of extracellular signal-regulated kinase, p44/p42 (ERK1/2) [17].”
Background5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail
Barclay, Z., Dickson, L., Robertson, D. N., Johnson, M. S., Holland, P. J., Rosie, R., Sun, L., Fleetwood‐Walker, S., Lutz, E. M., & Mitchell, R. (2011) · Biochemical Journal · doi:10.1042/bj20101844 · Cited by 20
The Gq and G12 Families of Heterotrimeric G Proteins Report Functional Selectivity
Zhang, L., Brass, L. F., & Manning, D. R. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050906 · Cited by 18
“A great deal of information regarding selectivity has been gained through studies of receptors for serotonin (Berg et al., 1998, 2001; Kurrasch-Orbaugh et al., 2003; De Deurwaerdère et al., 2004), dopamine (Lawler et al., 1999; Kilts et al., 2002; Mottola et al., 2002; Gay et al., 2004;…”
BackgroundStahl, E. L., Elmslie, G., & Ellis, J. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072991 · Cited by 18
“Kurrasch-Orbaugh et al. (2003a) found that different 5HT2A receptor agonists possessed opposite functional selectivity for the two responses in NIH-3T3 cells; indeed, these authors also found different magnitudes of receptor reserve for the two responses.”
BackgroundKleffens, M. D.-V., Zimmermann-Klemd, A. M., & Gründemann, C. (2023) · Molecules · doi:10.3390/molecules28247942 · Cited by 20
Arrate, I. M., Miranda-Azpiazu, P., Horrillo, I., Dı́ez-Alarcia, R., & Meana, J. J. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16368 · Cited by 19
Catlow, B. J., Jalloh, A., & Sanchez‐Ramos, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00077-7 · Cited by 18
Natural Psychoplastogens As Antidepressant Agents
Benko, J., & Vranková, S. (2020) · Molecules · doi:10.3390/molecules25051172 · Cited by 17
“Increased [Ca2+] leads to activation of the cascade, including protein kinase C (PKC), mitogen-activated protein kinase (MAPK), and cAMP response-element binding protein (CREB).”
BackgroundInfluentialMcNamara, R. K., Szeszko, P. R., Smesny, S., Ikuta, T., DeRosse, P., Vaz, F. M., Milleit, B., Hipler, U., Wiegand, C., Hesse, J., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.12.007 · Cited by 16
“…case of membrane damage, the activity of cPLA2 and iPLA2 (as inPLA2 sum activity) in turn is increased by interaction with extracellular secretory non-pancreatic, and calcium-dependent PLA2 isoenzymes (Garcia and Kim, 1997; Balsinde et al., 1998; Kuwata et al., 2000; Kurrasch-Orbaugh et al., 2003).”
BackgroundMurnane, K. S., Güner, O. F., Bowen, J. P., Rambacher, K. M., Moniri, N. H., Murphy, T. J., Daphney, C. M., Oppong‐Damoah, A., & Rice, K. C. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.04.003 · Cited by 16
Santini, M. A., Klein, A. B., El-Sayed, M., Ratner, C., Knudsen, G. M., Mikkelsen, J. D., & Aznar, S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.048 · Cited by 15
Mercier, F., Morin, C., Cloutier, M., Proteau, S., Rokach, J., Powell, W. S., & Rousseau, É. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00005.2004 · Cited by 15
“In addition to its involvement in Ca(2) sensitization, the Rho-kinase pathway has also been shown to be involved in agonist-induced stimulation of arachidonic acid release from fibroblasts, presumably mediated by activation of cPLA2 (18).”
BackgroundSerotonin Modulation of Dorsoventral Hippocampus in Physiology and Schizophrenia
Kandilakis, C. L., & Papatheodoropoulos, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157253 · Cited by 14
Jastrzębski, M. K., Wójcik, P., Grudzińska, A., Andreozzi, G., Vetrò, T., Asim, A., Mudgal, A., Czapiński, J., Wróbel, T. M., Bartuzi, D., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.002 · Cited by 15
“Phospholipase A2 is activated through interactions between 5-HT 2A and G 12/13 proteins 29 , while phospholipase D directly binds to both 5-HT 2A receptors and ADP-ribosylation factor (Arf) 30 .”
Soto, C. A., Shashack, M. J., Fox, R. G., Bubar, M. J., Rice, K. C., Watson, C. S., Cunningham, K. A., Gilbertson, S. R., & Anastasio, N. C. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00309 · Cited by 13
Martín‐Guerrero, S. M., Alonso-Batan, P., Iglesias, A., Cimadevila, M., Brea, J. M., Loza, M. I., Casado, P., Martín‐Oliva, D., Cutillas, P. R., González‐Maeso, J., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114440 · Cited by 13
Bhattacharjee, A. K., Meister, L. M., Chang, L., Bazinet, R. P., White, L., & Rapoport, S. I. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.06.012 · Cited by 13
“These receptors, like D2-receptors, can be coupled to cPLA2 to release AA from membrane phospholipid (Berg et al., 1998; Garcia and Kim, 1997; Kurrasch-Orbaugh et al., 2003; Qu et al., 2003).”
BackgroundAngiotensin II stimulates fibronectin protein synthesis via a Gβγ/arachidonic acid-dependent pathway
Alexander, L. D., Ding, Y., Alagarsamy, S., & Cui, X.-L. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00094.2014 · Cited by 12
Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder
Alexander, C., & Vasefi, M. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.08.001 · Cited by 12
“…et al., 2020; Avery et al., 2014; Cheng et al., 2003, 2006; Dong et al., 2001; Helmstetter (1992); Helmstetter and Bellgowan, 1993; Knight et al., 2005; LaBar et al., 1998; Maren (2001); Ono et al., 1985; Pitkänen et al., 1997; Veening et al., 1984; Weller and Smith, 1982; Wilensky et al., 2006).”
Selectivity for G Protein or Arrestin-Mediated Signaling
Bohn, L. (2009) · The Receptors · doi:10.1007/978-1-60327-335-0_5 · Cited by 11
Serotonin 2C receptors are also important in head-twitch responses in male mice
Custodio, R. J. P., Ortiz, D. M., Lee, H. J., Sayson, L. V., Buctot, D., Kim, M., Lee, Y. S., Cheong, J. H., Cheong, J. H., & Kim, H. J. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06482-9 · Cited by 16
Serotonin 2A receptors and cannabinoids
Ibarra‐Lecue, I., Dı́ez-Alarcia, R., & Urigüen, L. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.004 · Cited by 11
Fryc, M., Kluzik, D., Czopek, A., Jończyk, J., & Zagórska, A. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110622 · Cited by 10
Ranjbaran, M., Kianian, F., Kadkhodaee, M., Seifi, B., Ashabi, G., Akhondzadeh, F., Adelipour, M., Izad, M. H., & Abdolmohammadi, K. (2022) · PubMed Central · doi:10.22038/ijbms.2022.61860.13690 · Cited by 9
“Reductions in the expression of 5-HT2A receptors and phosphorylation of ERK1/2 and an increase in the expression of 5-HT1A receptors in the hippocampal tissue samples were observed in the MSC and CM groups.”
InfluentialAre we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?
Qureshi, O., Cowley, J., Pegg, A., Cooper, A. J., Gordon, J., Brady, C., Belli, A., Butterworth, S., Upthegrove, R., Andrews, N., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70138 · Cited by 11
Zulfiker, A., Hashimi, S., Good, D., Grice, I., & Wei, M. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25627 · Cited by 8
“Agonists working on 5-HT2AR may stimulate several signal transduction pathways, such as activation of MAPK, PLC-b, and PLA2 [Kurrasch-Orbaugh et al., 2003] leading to longterm transcriptional changes.”
BackgroundJensen, N. (2005) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-2111 · Cited by 9
Biased Signaling in Psychedelic Action
Wacker, D., & McCorvy, J. D. (2025) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-062124-012545 · Cited by 9
Pirenperone relieves the symptoms of fragile X syndrome in Fmr1 knockout mice
Kim, Y., Jeon, S. J., Gonzales, E. L., Shin, D., Remonde, C. G., Ahn, T., & Shin, C. Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-25582-8 · Cited by 7
Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets
de Sousa, T. R., Rema, J., Machado, S. E. D. C., & Novais, F. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666211201145800 · Cited by 7
la Cour, C. M., Chaput, C., Touzard, M., & Millan, M. J. (2008) · Synapse · doi:10.1002/syn.20587 · Cited by 7
Roméo, B., Kervadec, E., Fauvel, B., Strika-Bruneau, L., Amirouche, A., Verroust, V., Piolino, P., & Benyamina, A. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111300 · Cited by 7
Metadata
- Authors
- Kurrasch‐Orbaugh, D. M., Parrish, J. C., Watts, V. J., & Nichols, D. E.
- Affiliations
- Purdue University West Lafayette (US)
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2003-07-21
- Volume
- 86
- Issue
- 4
- Pages
- 980-991
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1523962342
- Cited by
- 138
- References
- 56
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 5 · 2023: 7 · 2022: 9 · 2021: 9 · 2020: 3 · 2019: 6 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 4 · 2014: 4 · 2013: 3 · 2012: 3
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse (DA 02189)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- phospholipase A2 activation, arachidonic acid release, mitogen-activated protein kinase, ERK1/2, p38 MAPK, Gα12/13, Gαi/o, Rho proteins, signal transduction, pertussis toxin
- MeSH terms
- Animals, Enzyme Activation, Enzyme Inhibitors, Fibroblasts, Inositol Phosphates, Type C Phospholipases, Phospholipases A, Receptors, Serotonin, Signal Transduction, 3T3 Cells, Arachidonic Acid, GTP-Binding Proteins, Mitogen-Activated Protein Kinase 1, Enzyme Activators, rho GTP-Binding Proteins, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Receptor, Serotonin, 5-HT2A, p38 Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3, Mice, Phospholipases A2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review